Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | AMGN | VRTX | REGN | GILD |
| Company | Structure Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 40.01 | 313.34 | 467.94 | 1,047.11 | 68.63 |
| High | 41.21 | 319.00 | 478.96 | 1,069.69 | 69.99 |
| Low | 39.75 | 312.53 | 467.86 | 1,045.00 | 68.50 |
| Last | 40.29 | 312.97 | 474.46 | 1,059.47 | 68.95 |
| Change | +1.02 | +0.52 | +5.74 | +8.44 | +0.34 |
| % Change | +2.60% | +0.17% | +1.22% | +0.80% | +0.50% |
| Volume | 345,286 | 424,810 | 300,410 | 141,805 | 1,968,778 |
| 20-Day Average Volume | 2,073,576 | 2,408,771 | 1,304,103 | 471,660 | 9,346,606 |
| Previous Close | 39.27 | 312.45 | 468.72 | 1,051.03 | 68.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 47.78 | 307.65 | 475.82 | 1,032.06 | 66.31 |
| 20-Day Raw Stochastic | 23.32% | 56.94% | 63.02% | 76.97% | 70.09% |
| 20-Day Relative Strength | 45.53% | 57.74% | 60.74% | 66.57% | 57.28% |
| Weighted Alpha | -15.98 | +37.62 | +41.95 | +49.91 | -8.71 |
| Today's Opinion | 32% Sell | 100% Buy | 88% Buy | 100% Buy | 24% Sell |
| Previous Opinion | 32% Sell | 100% Buy | 88% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 100% Sell | 72% Buy | 88% Buy | 72% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.59% since 06/24/24 | -1.67% since 06/24/24 | -0.13% since 06/24/24 | -0.58% since 06/24/24 | -1.97% since 06/24/24 |
| Low | 36.45 on 06/26/24 | 310.59 on 06/28/24 | 467.67 on 06/28/24 | 1,041.78 on 06/28/24 | 68.06 on 06/28/24 |
| High | 43.54 on 06/25/24 | 326.12 on 06/25/24 | 483.92 on 06/25/24 | 1,081.17 on 06/25/24 | 71.48 on 06/25/24 |
| 1-Month | |||||
| %Chg | +18.03% since 05/31/24 | +2.29% since 05/31/24 | +4.17% since 05/31/24 | +7.91% since 05/31/24 | +7.89% since 05/31/24 |
| Low | 33.56 on 06/03/24 | 295.30 on 06/13/24 | 453.73 on 06/03/24 | 979.26 on 06/03/24 | 62.69 on 06/18/24 |
| High | 62.74 on 06/03/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.18 on 06/21/24 |
| 3-Month | |||||
| %Chg | -1.31% since 04/01/24 | +10.53% since 04/01/24 | +12.81% since 04/01/24 | +9.12% since 04/01/24 | -4.86% since 04/01/24 |
| Low | 33.56 on 06/03/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 62.74 on 06/03/24 | 326.12 on 06/25/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 72.85 on 04/02/24 |
| 6-Month | |||||
| %Chg | -0.97% since 12/29/23 | +8.62% since 12/29/23 | +16.58% since 12/29/23 | +20.43% since 12/29/23 | -14.41% since 12/29/23 |
| Low | 33.56 on 06/03/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 871.39 on 01/02/24 | 62.07 on 05/31/24 |
| High | 62.74 on 06/03/24 | 329.72 on 02/05/24 | 486.42 on 06/07/24 | 1,081.17 on 06/25/24 | 87.86 on 01/19/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,830,728 | 167,609,120 | 120,954,608 | 115,808,784 | 85,477,984 |
| Shares Outstanding, K | 46,619 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -89,620,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 6,686,000,000 |
| Last Quarter Net Income | -26,040,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -4,170,000,000 |
| 60-Month Beta | N/A | 0.60 | 0.41 | 0.13 | 0.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -1.32 on 04/25/24 |
| Latest Earnings Date | 08/08/24 | 08/01/24 | 08/06/24 | 08/01/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 06/14/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.84 | 31.38 | 28.32 | 17.08 |